Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-012261
Filing Date
2022-05-05
Accepted
2022-05-05 16:31:55
Documents
92
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 form10q.htm   iXBRL 10-Q 1079305
2 ex31-1.htm EX-31.1 18056
3 ex31-2.htm EX-31.2 18122
4 ex32-1.htm EX-32.1 8006
  Complete submission text file 0001493152-22-012261.txt   6845263

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE hrow-20220331.xsd EX-101.SCH 59829
6 XBRL CALCULATION FILE hrow-20220331_cal.xml EX-101.CAL 83371
7 XBRL DEFINITION FILE hrow-20220331_def.xml EX-101.DEF 300422
8 XBRL LABEL FILE hrow-20220331_lab.xml EX-101.LAB 479260
9 XBRL PRESENTATION FILE hrow-20220331_pre.xml EX-101.PRE 397019
86 EXTRACTED XBRL INSTANCE DOCUMENT form10q_htm.xml XML 1024413
Mailing Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215
Business Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215 615.733.4731
HARROW HEALTH, INC. (Filer) CIK: 0001360214 (see all company filings)

EIN.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35814 | Film No.: 22896908
SIC: 2834 Pharmaceutical Preparations